News
The Future of Clinical Trials: How Retinal Imaging is Changing the Game
What if we told you that retinal imaging provides powerful biomarkers for inherited retinal diseases dry AMD ?
With the rise of precision medicine, retinal imaging continues to emerge as a key tool for clinical trials – allowing the detection of subtle cellular changes that indicate disease progression and treatment efficacy sooner than ever before.
Thanks to our distributor partnership with Imagine Eyes, Emsere is bringing the rtx1 Adaptive Optics Retinal Camera to clinical trial sites worldwide.
Why is this technology groundbreaking?
✅ Unprecedented resolution – Cellular and microvascular details reveal early microlesions and minute progression of retinal disease
✅ Optimized patient selection – Through phenotyping at the microscopic level
✅ Early signals of treatment efficacy – Detected on 5x shorter time scales
✅ Sensitive detection of potential side effects – At the level of cells and vessel walls
✅ Objective Imaging Biomarkers – Regulatory bodies are increasingly valuing imaging-based endpoints, making the rtx1 AO camera worth integrating into next-generation trials.
Want to see it in action? Visit Imagine Eyes at ARVO 2025!
◾ Explore the rtx1 Adaptive Optics Retinal Camera firsthand
◾ Discover how high-resolution imaging is transforming clinical research
◾ Discuss how we can support your trial needs with global access
◾ Drop by the booth, say hi to Bryan M. Dunlap, scan the QR code at the booth and get a chance to win a Starbucks coffee voucher on us!
📍 Booth 1409 | May 4–8, 2025 | Salt Lake City, Utah
“At Imagine Eyes, we strive to redefine what’s possible in retinal imaging,” said Nicolas Chateau, CEO of Imagine Eyes. “With Emsere’s global reach, we can now equip more clinical investigators with the tools they need to the development of new therapies.”
This partnership isn’t just about technology—it’s about accelerating breakthroughs that improve patient outcomes.
💡 Are you incorporating advanced imaging solutions in your trials? Let’s discuss how retinal imaging can shape the future of clinical research.